On May 20 the Disease Foundation hosted its third annual award reception at Digestive Disease Week in Washington, D.C. From prestigious global research prizes to inaugural student and policy leadership awards, the event spotlighted the extraordinary contributions of individuals dedicated to improving the lives of those affected by celiac disease.
Continue ReadingThe Celiac Disease Foundation has joined forces with the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Foundation to introduce two groundbreaking awards specifically designed to advance celiac disease research. These initiatives aim to foster novel research endeavors, emphasizing the importance for medical professionals to delve into the complexities of this lifelong autoimmune condition.
Continue ReadingThe Celiac Disease Foundation today announced its Board of Directors re-appointments for 2024. The Board represents a diverse mix of professionals, patients, and caregivers who are deeply committed to advancing the Foundation’s mission of accelerating diagnosis, treatments, and a cure for celiac disease.
Continue ReadingThe Celiac Disease Foundation, the nation’s leading patient advocacy organization for celiac disease, today is proud to announce its newest Board of Directors appointee, Dan Gibbons, who joins the organization this month.
Continue ReadingThis year, we are proud to acknowledge the outpouring of support we received during the month of May.
Continue ReadingDDW 2023 showcased some of the latest research and innovations in celiac disease. These included promising early results from four investigational medications currently being tested for the treatment of celiac disease, as well as CDF research conducted in partnership with Takeda and Adelphi Real World.
Continue ReadingThe Celiac Disease Foundation is pleased to announce it will provide patient recruitment and eligibility screening for Anokion’s phase 1b/2 clinical trial for KAN-101.
Continue ReadingThe Celiac Disease Foundation announces its newest appointee, William Thurston, to its Board of Directors.
Continue ReadingThe FDA released the long-awaited draft guidance, “Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet."
Continue ReadingAnokion SA released successful results from their Phase 1 ACeD clinical trial and they will be moving forward with Phase 2 trials later this year.
Continue ReadingLast month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...